Standout Papers

Talazoparib monotherapy in metastat... 2012 2026 2016 2021 3.3k
  1. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial (2021)
    Johann S. de Bono, Niven Mehra et al. The Lancet Oncology
  2. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy (2012)
    Howard I. Scher, Karim Fizazi et al. New England Journal of Medicine

Immediate Impact

25 from Science/Nature 107 standout
Sub-graph 1 of 17

Citing Papers

Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma
2023 StandoutNature
26 intermediate papers

Works of Mark T. Fleming being referenced

A Phase II Trial of Temsirolimus in Men With Castration-Resistant Metastatic Prostate Cancer
2013
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Mark T. Fleming 3688 1525 527 1296 120 6.0k
David Harrington 3567 3735 909 2117 123 8.1k
Carol M. Moinpour 4456 4480 766 1026 117 9.3k
William K. Evans 4321 5542 876 1571 254 10.2k
Valerie McCormack 2205 3514 534 695 131 7.0k
Stephen H. Taplin 1713 5802 414 309 167 9.0k
Lawrence N. Shulman 2060 6456 1216 1151 326 11.4k
Marc Botteman 881 1160 1288 685 208 5.3k
Jane Warwick 1047 2009 630 352 100 4.4k
Kyu‐Won Jung 3791 4927 3000 1436 191 11.4k
Justin E. Bekelman 1499 1155 1040 126 201 5.5k

All Works

Loading papers...

Rankless by CCL
2026